Titre : |
Phelan-McDermid Syndrome: Clinical Aspects |
Type de document : |
Texte imprimé et/ou numérique |
Auteurs : |
Katy PHELAN, Auteur ; Luigi BOCCUTO, Auteur ; Sara SARASUA, Auteur |
Année de publication : |
2016 |
Importance : |
p.347-364 |
Langues : |
Anglais (eng) |
Mots-clés : |
22q13 deletion Absent speech Autism Dysplastic toenails Hypotonia Intellectual impairment Phelan–McDermid SHANK3 Speech delay |
Index. décimale : |
SCI-D SCI-D - Neurosciences |
Résumé : |
Phelan–McDermid syndrome (PMS), also known as the 22q13 deletion syndrome, is a genetic condition characterized by neonatal hypotonia, developmental delay, absent or impaired speech, and minor dysmorphic features. PMS typically results from a deletion of the distal long arm of chromosome 22, with the size of the deleted segment ranging from less than 100 kb to greater than 9 MB. The loss of 22q13 may result from a terminal deletion, an interstitial deletion, an unbalanced translocation, formation of a ring chromosome, or other types of structural chromosome aberrations. In most cases, the deletion results in haploinsufficiency for the SHANK3 gene which codes for a scaffolding protein in the postsynaptic density of excitatory neurons. Mutation or disruption of the SHANK3 gene may also result in PMS. The diagnosis of PMS relies on laboratory confirmation by molecular cytogenetic or molecular genetic methods. |
En ligne : |
http://dx.doi.org/10.1016/B978-0-12-800109-7.00021-2 |
Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=301 |
Phelan-McDermid Syndrome: Clinical Aspects [Texte imprimé et/ou numérique] / Katy PHELAN, Auteur ; Luigi BOCCUTO, Auteur ; Sara SARASUA, Auteur . - 2016 . - p.347-364. Langues : Anglais ( eng)
Mots-clés : |
22q13 deletion Absent speech Autism Dysplastic toenails Hypotonia Intellectual impairment Phelan–McDermid SHANK3 Speech delay |
Index. décimale : |
SCI-D SCI-D - Neurosciences |
Résumé : |
Phelan–McDermid syndrome (PMS), also known as the 22q13 deletion syndrome, is a genetic condition characterized by neonatal hypotonia, developmental delay, absent or impaired speech, and minor dysmorphic features. PMS typically results from a deletion of the distal long arm of chromosome 22, with the size of the deleted segment ranging from less than 100 kb to greater than 9 MB. The loss of 22q13 may result from a terminal deletion, an interstitial deletion, an unbalanced translocation, formation of a ring chromosome, or other types of structural chromosome aberrations. In most cases, the deletion results in haploinsufficiency for the SHANK3 gene which codes for a scaffolding protein in the postsynaptic density of excitatory neurons. Mutation or disruption of the SHANK3 gene may also result in PMS. The diagnosis of PMS relies on laboratory confirmation by molecular cytogenetic or molecular genetic methods. |
En ligne : |
http://dx.doi.org/10.1016/B978-0-12-800109-7.00021-2 |
Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=301 |
|